Crucial role of CD4+CD 25+ FOXP3+ T regulatory cell, interferon-γ and interleukin-16 in malignant and tuberculous pleural effusions

Immunological Investigations

Volumn 42, Issue 2, 2013, Pages 122-136

  Ibrahim, Lamiaa ^a   Salah, Manal ^a   Rahman, Azema Abd El ^a   Zeidan, Amany ^a   Ragb, Maha ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Flow cytometry; Interferon gamma; Interleukin 16; Pleural effusion; T regulatory cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 16; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; BLOOD; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PHENOTYPE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUBERCULOSIS;

ADULT; AGED; ANTIGENS, CD4; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-16; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS, PLEURAL;

EID: 84872434823     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2012.736116     Document Type: Article

References (33)

1. Aoe, K., Hiraki, A., Murakami, T., et al. (2003). Diagnostic significance of interferon-γ in tuberculous pleural effusions. Chest 123:740-744. (Pubitemid 36315487)
2. Baxevanis, C., Dedoussis, G., Gritzapis, A., Stathopoulos, G.P., Papamichail, M. (1994). Interleukin 1β synergises with interleukin 2 in the outgrowth of autologous tumorreactive CD8+ effectors. Br. J. Cancer 70:625-630.
3. Chen, Y., Yang, W., Whang-Peng, J., et al. (1996). Elevation of interleukin-10 levels in malignant pleural effusion. Chest 110:433-436. (Pubitemid 26269274)
4. CruikshankW,Kornfeld H,CenterDM. (2000). Interleukin-16. J. Leukoc.Biol. 67:757-766.
5. Cui, H., Zhang, Q., Su, B., Li, W., Tang, S. (2010). Differential levels of cytokines and soluble Fas ligand between tuberculous and malignant effusions. J. Int. Med. Res. 2010; 38(6):2063-2069.
6. Dalbeth, N., Lee, Y. (2005). Lymphocytes in pleural disease. Curr. Opin. Pulm. Med. 2005;11:334-339. (Pubitemid 41073159)
7. de Aguiar. L., Antonangelo, L.; Vargas, F., Zerbini, M., Sales, M., Uip, D., Saldiva, P. (2008). Malignant and tuberculous pleural effusions: Immunophenotypic cellular characterization. Clinics 63(5):637-644.
8. Dlugovitzky, D., Torres-Morales, A., Rateni, L., Farroni, M., Largacha, C., Molteni, O., Bottasso, O. (1997). Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol. Med. Microbiol. 18(3):203-207. (Pubitemid 27323702)
9. Fontenot, J., Rudensky, A. (2005). A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 6(4):331-337. (Pubitemid 41716769)
10. Guyot-Revol, V., Innes, J., Hackforth, S., Hinks, T., Lalvani, A. (2006). Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am. J. Respir. Crit. Care Med. 173:803-810.
11. Krenke, R., Safianowska, A., Papliska, M., Korczyski, P., Dmowska-Sobstyl, B., Bogacka-Zatorska, E., et al. (2008). Pleural fluid interferon-gamma (IFN-gamma) measurement as a diagnostic tool in tuberculous pleurisy. Pneumonol. Alergol. Pol. 76(4):237-245.
12. Kroegel, C., Antony, V. (1997). Immunobiology of pleural inflammation: potencial implications for pathogenesis, diagnosis and therapy. Eur. Respir. J. 10:2411-2418. (Pubitemid 27479569)
13. Li, L., Chao, Q., Ping, L., Xue, C., Xia, Z., Qian, D., Shi-Ang, H. (2009). The prevalence of FOXP3 regulatory T-cells in peripheral blood of patients with NSCLC. Cancer Biother. Radiopharm. 24(3):357-367.
14. Li, YH., Xie, CM. (2004). A study on the Th1/Th2 cytokines in the pathogenesis of human tuberculous pleuritis. Zhonghua Jie He He Hu Xi Za Zhi 27(5):324-327.
15. Liam, C. K., Lim, K. H., Wong, C. M. (2000). Differences in pleural fluid characteristics, white cell count and biochemistry of tuberculous and malignant pleural effusions. Med J. Malaysia 55(1):21-28.
16. Light, R., MacGregor, M., Luchsinger, P., Ball, W. (1972). Pleural effusions: the diagnostic separation of transudates and exudates. Ann. Intern. Med. 77:507-513.
17. Mantovani, G., Macciò, A., Versace, R., Pisano, M., Lai, P., Esu, S., et al. (1995). Tumorassociated lymphocytes (TAL) are competent to produce higher levels of cytokines in neoplastic pleural and peritoneal effusions than those found in sera and are able to release into culture higher leves of IL-2 and IL-6 than those released by PBMC. J. Mol. Med. 73:409-416.
18. Mao, C., Wang, S., Jiang, Q., Tong, J., Ma, J., Yang, M., et al. (2008). Increased CD4CD25+FOXP3+ regulatory T Cells in cancer patients from conversion of CD4+CD25-T cells through tumor-derived factors. Onkologie 31(5):243-248. (Pubitemid 351744824)
19. O'Garra, A., Vieira, P. (2004). Regulatory T cells and mechanisms of immune system control. Nat. Med. 10(8):801-805. (Pubitemid 39070850)
20. Okamoto, M., Hasegawa, Y., Hara, T., et al. (2005). T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Chest 128:4030-4035. (Pubitemid 43062668)
21. Qin, X., Shi, H., Huang, Z., Kang, L., Mo, W., Wu, C. (2005). Interleukin-16 in tuberculous and malignant pleural effusions. Eur. Respir. J. 25:605-611. (Pubitemid 40528751)
22. Qin, X., Shi, H., Liang, Q., Huang, L., Yang, H. (2008). CD4+CD25+ regulatory T lymphocytes in tuberculous pleural effusion. Chin. Med. J. 121(7):581-586.
23. Qin, X., Shi, H., Liang, Q., Huang, L., Yang, H. (2008). CD4-CD25-regulatory T lymphocytes in tuberculous pleural effusion. Chin. Med. J. 121:581-586.
24. Research. On-line bibliography available from: 〈http://splweb.bwh. harvard.edu:8000/pages/ppl/zou/roc.html〉.
25. Ribeiro-Rodrigues, R., Resende, Co. T., Rojas, R., Toossi, Z., Dietze, R., Boom, W., et al. (2006). A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin. Exp. Immunol. 144:25-34.
26. Sawan, S., Burt, D. J., Stern, P. L., Holland, C., Elkord, E. (2011). Circulating regulatory T cells in endometrial cancer: A role for age and menopausal status. Immunol. Invest. 40:62-75.
27. Shevach E. (2002). CD4+CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389-400. (Pubitemid 37328746)
28. Shi, H. Z., Qin, X. J. (2005). CD4+CD25+ regulatory T lymphocytes in allergy and asthma. Allergy 60:986-995.
29. Thornton, A., Shevach, E. (2000). Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183-190. (Pubitemid 30012989)
30. Wu, C., Zhou, Q., Qin, X., Qin, S., Shi, H. (2010). CCL22 is involved in the recruitment of CD4-CD25 high T cells into tuberculous pleural effusions. Respirology 15:522-529.
31. Yang, C., Lee, J., Lee, H., et al. (2008). Differential cytokine levels and immunoreactivities against Mycobacterium tuberculosis antigens between tuberculous and malignant effusions. Respir. Med. 102:280-286. (Pubitemid 350296902)
32. Yang, H., Shi, H. (2008). T lymphocytes in pleural effusion. Chin. Med. J. 121:579-580.
33. Zou, K.H. (2002). Receiver operating characteristic (ROC) literature research. On-line bibliography available from: 〈http://splweb.bwh.harvard. edu:8000/pages/ppl/zou/roc.html.